Intranasal carbetocin, an oxytocin analog has also been tested in PWS in a short (2-week) study and showed improvement in hyperphagia and some behavioral symptoms with an unusually high placebo response [28]. This evidence concerns the gene OXT and Prader-Willi syndrome.